2 assets in Autoimmune Hepatitis

Therapeutic assets addressing Autoimmune Hepatitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Orbcel-C Autoimmune Hepatitis	University of Birmingham	P1/2	CCC (48)
Siplizumab Autoimmune Hepatitis	Elizabeth C. Verna	P1	C (33)